LIRAGLUTIDE-DEGLUDEC FIXED DOSE COMBINATION IMPROVES NASH/NAFLD IN PATIENTS WITH UNCONTROLLED TYPE II DIABETES MELLITUS

被引：0
|
作者：
Singh, K. P. [1 ]
Bindra, N. [1 ]
Prem, S. [1 ]
Chhabra, M. [2 ]
Rathi, V. [1 ]
Sharma, R. [1 ]
Rai, P. E. [1 ]
机构：
[1] Fortis Hosp, Endocrinol, Mohali, India
[2] Fortis Hosp, Gastroenterol, Mohali, India
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
098
引用
收藏
页码：A44 / A45
页数：2
相关论文
共 50 条
  • [1] Cost Effectiveness of Insulin Degludec Plus Liraglutide (IDegLira) in a Fixed Combination for Uncontrolled Type 2 Diabetes Mellitus in Sweden
    Åsa Ericsson
    Adam Lundqvist
    Applied Health Economics and Health Policy, 2017, 15 : 237 - 248
  • [2] Cost Effectiveness of Insulin Degludec Plus Liraglutide (IDegLira) in a Fixed Combination for Uncontrolled Type 2 Diabetes Mellitus in Sweden
    Ericsson, Asa
    Lundqvist, Adam
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2017, 15 (02) : 237 - 248
  • [3] HDL LIPIDOMIC ANALYSIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS RECEIVING FIXED-DOSE COMBINATION OF INSULIN DEGLUDEC AND LIRAGLUTIDE
    Pappa, E.
    Vavli, E.
    Kostara, C.
    Bairaktari, E.
    Tsimihodimos, V.
    ATHEROSCLEROSIS, 2020, 315 : E65 - E65
  • [4] EFFECT OF THE FIXED-DOSE COMBINATION OF INSULIN DEGLUDEC AND LIRAGLUTIDE ON SERUM LIPOPROTEIN METABOLISM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Pappa, E.
    Arvaniti, E.
    Dimou, A.
    Kostara, C.
    Tellis, K.
    Tselepis, A.
    Bairaktari, E.
    Elisaf, M.
    Tsimihodimos, V.
    ATHEROSCLEROSIS, 2019, 287 : E127 - E128
  • [5] The Effect of Fixed-Dose Combination of Insulin Degludec and Liraglutide on Serum Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus
    Pappa, Eleni
    Kostara, Christina
    Tellis, Constantinos
    Tselepis, Alexandros D.
    Bairaktari, Eleni
    Tsimihodimos, Vasilis
    DIABETES, 2020, 69
  • [6] Fixed-ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin
    Vilsboll, Tina
    Blevins, Thomas C.
    Jodar, Esteban
    Poulter, Neil
    Tentolouris, Nikolaos
    Agner, Bue F. Ross
    Lehmann, Lucine
    Leiter, Lawrence A.
    DIABETES OBESITY & METABOLISM, 2019, 21 (06): : 1506 - 1512
  • [7] Triglyceride Reduction and Effect on Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus Receiving Fixed-Dose Combination of Insulin Degludec and Liraglutide
    Pappa, Eleni
    Kostara, Christina
    Dimou, Aikaterini
    Bairaktari, Eleni T.
    Tsimihodimos, Vasilis
    DIABETES, 2021, 70
  • [8] Fixed Combination of Insulin Degludec and Liraglutide in Type 2 Diabetes Treatment
    Jaecke, E.
    Wilhelm, B.
    Kaiser, M.
    DIABETES STOFFWECHSEL UND HERZ, 2015, 24 (06): : 387 - 395
  • [9] Liraglutide Improves NAFLD in Patients with Type 2 Diabetes
    Basu, Debasis
    Chaudhuri, Soumyabrata Roy
    Deka, Nilakshi
    DIABETES, 2020, 69
  • [10] The Effect of Combination Therapy of Degludec and Liraglutide in Hospitalized Patients with Uncontrolled Type 2 Diabetes (T2DM)
    Akiyama, Tomoaki
    Yamada, Masayo
    Katsuragawa, Sho
    Terui, Sakiko
    Minami, Taichi
    Terauchi, Yasuo
    DIABETES, 2017, 66 : A295 - A295
12345